DA
Dhanwanti Arvind Devjani
About Dhanwanti Arvind Devjani
Data last updated:
Dhanwanti Arvind Devjani is a Director at Truelixir Biotech Private Limited (since 2020) and Director at Smatt Medichem Private Limited (since 2023). The companies operate in Healthcare and Paper. The largest current company by reported revenue is Truelixir Biotech Private Limited at ₹1.12 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Truelixir Biotech Private Limited U15100MP2020PTC051897 | Director | 19 Jul 2020 | 2020 | ₹1.12 Cr (FY 2025) | Active |
 Smatt Medichem Private Limited U21001MP2023PTC067804 | Director | 19 Sep 2023 | 2023 | Active |
Board colleagues of Dhanwanti Arvind Devjani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Arvind Shanker Devjani | 08800017 | Truelixir Biotech Private Limited , Smatt Medichem Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dhanwanti Arvind Devjani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dhanwanti Arvind Devjani
Dhanwanti Arvind Devjani currently holds 2 directorships: Truelixir Biotech Private Limited (Director, since 19 Jul 2020, revenue ₹1.12 Cr (FY 2025)); Smatt Medichem Private Limited (Director, since 19 Sep 2023).
Dhanwanti Arvind Devjani was first appointed on 19 Jul 2020 as Director at Truelixir Biotech Private Limited. The most recent appointment on record is 19 Sep 2023 at Smatt Medichem Private Limited.
The current boards of Dhanwanti Arvind Devjani's companies include Arvind Shanker Devjani (Truelixir Biotech Private Limited).